Bone development is extremely sensitive to alterations in thyroid status. Recently, we analyzed the skeletal phenotypes of mice with the dominant negative resistance to thyroid hormone (RTH) mutation PV targeted to either the thyroid hormone receptor (TR) α1 or β gene. This perspective summarizes our findings to date and explores the wider implications for thyroid status and T3 target gene expression in individual tissues.
References
1.
AbelE. D., AhimaR. S., BoersM. E., ElmquistJ. K., and WondisfordF. E. (2001). Critical role for thyroid hormone receptor beta2 in the regulation of paraventricular thyrotropin-releasing hormone neuronsJ Clin Invest107, 1017–23.
2.
AbelE. D., MouraE. G., AhimaR. S., Campos-BarrosA., Pazos-MouraC. C., BoersM. E., KaulbachH. C., ForrestD., and WondisfordF. E. (2003). Dominant inhibition of thyroid hormone action selectively in the pituitary of thyroid hormone receptor-β null mice abolishes the regulation of thyrotropin by thyroid hormoneMol Endocrinol17, 1767–76.
3.
BallockR., MitaB. C., ZhouX., ChenD. H., and MinkL. M. (1999). Expression of thyroid hormone receptor isoforms in rat growth plate cartilage in vivoJ Bone Miner Res14, 1550–6.
4.
BaxterJ. D., DillmannW. H., WestB. L., HuberR., FurlowJ. D., FletterickR. J., WebbP., AprilettiJ. W., and ScanlanT. S. (2001). Selective modulation of thyroid hormone receptor actionJ Steroid Biochem Mol Biol76, 31–42.
5.
BrentG. A. (2000). Tissue-specific actions of thyroid hormone: insights from animal modelsRev Endocr Metab Disord1, 27–33.
6.
ChengS. Y. (2000). Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptorsRev Endocr Metab Disord1, 9–18.
7.
DupreS. M., GuissoumaH., FlamantF., SeugnetI., ScanlanT. S., BaxterJ. D., SamarutJ., DemeneixB. A., and BeckerN. (2004). Both thyroid hormone receptor (TR)β 1 and TR β 2 isoforms contribute to the regulation of hypothalamic thyrotropin-releasing hormoneEndocrinology145, 2337–45.
8.
EsakiT., SuzukiH., CookM., ShimojiK., ChengS. Y., SokoloffL., and NunezJ. (2004). Cardiac glucose utilization in mice with mutated α-and β-thyroid hormone receptorsAm J Physiol Endocrinol Metab287, E1149–53.
9.
FlamantF., and SamarutJ. (2003). Thyroid hormone receptors: lessons from knockout and knock-in mutant miceTrends Endocrinol Metab14, 85–90.
10.
ForrestD., SjobergM., and VennstromB. (1990). Contrasting developmental and tissue-specific expression of α and β thyroid hormone receptor genesEmbo J9, 1519–28.
11.
ForrestD., HanebuthE., SmeyneR. J., EverdsN., StewartC. L., WehnerJ. M., and CurranT. (1996). Recessive resistance to thyroid hormone in mice lacking thyroid hormone receptor β: evidence for tissue-specific modulation of receptor functionEmbo J15, 3006–15.
12.
GauthierK., PlaterotiM., HarveyC. B., WilliamsG. R., WeissR. E., RefetoffS., WillottJ. F., SundinV., RouxJ. P., MalavalL., HaraM., SamarutJ., and ChassandeO. (2001). Genetic analysis reveals different functions for the products of the thyroid hormone receptor α locusMol Cell Biol21, 4748–60.
13.
GlossB., TrostS., BluhmW., SwansonE., ClarkR., WinkfeinR., JanzenK., GilesW., ChassandeO., SamarutJ., and DillmannW. (2001). Cardiac ion channel expression and contractile function in mice with deletion of thyroid hormone receptor α or βEndocrinology142, 544–50.
14.
GotheS., WangZ., NgL., KindblomJ. M., BarrosA. C., OhlssonC., VennstromB., and ForrestD. (1999). Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturationGenes Dev13, 1329–41.
15.
GuissoumaH., GhorbelM. T., SeugnetI., OuatasT., and DemeneixB. A. (1998). Physiological regulation of hypothalamic TRH transcription in vivo is T3 receptor isoform specificFaseb J12, 1755–64.
16.
GullbergH., RudlingM., ForrestD., AngelinB., and VennstromB. (2000). Thyroid hormone receptor β-deficient mice show complete loss of the normal cholesterol 7alpha-hydroxylase (CYP7A) response to thyroid hormone but display enhanced resistance to dietary cholesterolMol Endocrinol14, 1739–49.
17.
HolsbergerD. R., KiesewetterS. E., and CookeP. S. (2005). Regulation of neonatal Sertoli cell development by thyroid hormone receptor alpha1Biol Reprod73, 396–403.
18.
KaneshigeM., SuzukiH., KaneshigeK., ChengJ., WimbrowH., BarlowC., WillinghamM. C., and ChengS. (2001). A targeted dominant negative mutation of the thyroid hormone α 1 receptor causes increased mortality, infertility, and dwarfism in miceProc Natl Acad Sci U S A98, 15095–100.
19.
KaneshigeM., KaneshigeK., ZhuX., DaceA., GarrettL., CarterT. A., KazlauskaiteR., PankratzD. G., Wynshaw-BorisA., RefetoffS., WeintraubB., WillinghamM. C., BarlowC., and ChengS. (2000). Mice with a targeted mutation in the thyroid hormone β receptor gene exhibit impaired growth and resistance to thyroid hormoneProc Natl Acad Sci U S A97, 13209–14.
20.
KvistadP. H., LovasK., BomanH., and MykingO. L. (2004). Retarded bone growth in thyroid hormone resistance. A clinical study of a large family with a novel thyroid hormone receptor mutationEur J Endocrinol150, 425–30.
21.
LiuY.Y., SchultzJ. J., and BrentG. A. (2003). A thyroid hormone receptor α gene mutation (P398H) is associated with visceral adiposity and impaired catecholamine-stimulated lipolysis in miceJ Biol Chem278, 38913–20.
22.
O'SheaP.J., BassettJ. H., SriskantharajahS., YingH., ChengS. Y., and WilliamsG. R. (2005). Contrasting skeletal phenotypes in mice with an identical mutation targeted to thyroid hormone receptor {α}1 or {β}Mol Endocrinol
23.
O'SheaP. J., HarveyC. B., SuzukiH., KaneshigeM., KaneshigeK., ChengS.Y., and WilliamsG. R. (2003). A thyrotoxic skeletal phenotype of advanced bone formation in mice with resistance to thyroid hormoneMol Endocrinol17, 1410–24.
24.
ParrillaR., MixsonA. J., McPhersonJ. A., McClaskeyJ. H., and WeintraubB. D. (1991). Characterization of seven novel mutations of the c-erbA β gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two “hot spot” regions of the ligand binding domainJ Clin Invest88, 2123–30.
25.
RobsonH., SieblerT., StevensD. A., ShaletS. M., and WilliamsG. R. (2000). Thyroid hormone acts directly on growth plate chondrocytes to promote hypertrophic differentiation and inhibit clonal expansion and cell proliferationEndocrinology141, 3887–97.
26.
StevensD. A., HarveyC. B., ScottA. J., O'SheaP. J., BarnardJ. C., WilliamsA. J., BradyG., SamarutJ., ChassandeO., and WilliamsG. R. (2003). Thyroid hormone activates fibroblast growth factor receptor-1 in boneMol Endocrinol17, 1751–66.
27.
TinnikovA., NordstromK., ThorenP., KindblomJ. M., MalinS., RozellB., AdamsM., RajanayagamO., PetterssonS., OhlssonC., ChatterjeeK., and VennstromB. (2002). Retardation of post-natal development caused by a negatively acting thyroid hormone receptor alpha1Embo J21, 5079–87.
28.
WeissR. E., and RefetoffS. (1996). Effect of thyroid hormone on growth. Lessons from the syndrome of resistance to thyroid hormoneEndocrinol Metab Clin North Am25, 719–30.
29.
WeissR. E., and RefetoffS. (2000). Resistance to thyroid hormoneRev Endocr Metab Disord1, 97–108.
30.
WikstromL., JohanssonC., SaltoC., BarlowC., Campos BarrosA., BaasF., ForrestD., ThorenP., and VennstromB. (1998). Abnormal heart rate and body temperature in mice lacking thyroid hormone receptor α 1Embo J17, 455–61.
31.
WilliamsG. R., BlandR., and SheppardM. C. (1994). Characterization of thyroid hormone (T3) receptors in three osteosarcoma cell lines of distinct osteoblast phenotype: interactions among T3, vitamin D3, and retinoid signalingEndocrinology135, 2375–85.
32.
ZhangX.Y., KaneshigeM., KamiyaY., KaneshigeK., McPhieP., and ChengS. Y. (2002). Differential expression of thyroid hormone receptor isoforms dictates the dominant negative activity of mutant β receptorMol Endocrinol16, 2077–92.
